These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3279379)

  • 1. [Use of cultured epidermis of human origin for demonstrating the acantholytic action of staphylococcal exfoliatin A].
    Gentilhomme E; Faure M; Arco A; Kanitakis J; Dumaine MH; Marmet D; Binder F; Fleurette J; Thivolet J
    Pathol Biol (Paris); 1988 Feb; 36(2):121-6. PubMed ID: 3279379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Action of staphylococcal exfoliative toxins on epidermal cell cultures and organotypic skin.
    Gentilhomme E; Faure M; Piemont Y; Binder P; Thivolet J
    J Dermatol; 1990 Sep; 17(9):526-32. PubMed ID: 1703553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Staphylococcal toxic epidermal necrolysis].
    Fritsch P
    Fortschr Med; 1978 Jul; 96(26-27):1361-5. PubMed ID: 149750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical syndromes caused by staphylococcal epidermolytic toxin.
    Edlich RF; Horowitz JH; Nichter LS; Silloway KA; Morgan RF
    Compr Ther; 1985 Apr; 11(4):45-8. PubMed ID: 3159536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Removal of amino-terminal extracellular domains of desmoglein 1 by staphylococcal exfoliative toxin is sufficient to initiate epidermal blister formation.
    Nishifuji K; Shimizu A; Ishiko A; Iwasaki T; Amagai M
    J Dermatol Sci; 2010 Sep; 59(3):184-91. PubMed ID: 20728315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxin in bullous impetigo and staphylococcal scalded-skin syndrome targets desmoglein 1.
    Amagai M; Matsuyoshi N; Wang ZH; Andl C; Stanley JR
    Nat Med; 2000 Nov; 6(11):1275-7. PubMed ID: 11062541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Staphylococcal toxin syndromes.
    Ginsburg CM
    Pediatr Infect Dis J; 1991 Apr; 10(4):319-21. PubMed ID: 2062629
    [No Abstract]   [Full Text] [Related]  

  • 8. [Experimental models for studying the effects induced by staphylococcal toxins A and B on human keratinocytes in culture].
    Arco A; Faure M; Piemont Y; Thivolet J
    Arch Ital Anat Embriol; 1991; 96(3):185-99. PubMed ID: 1817457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Staphylococcal exfoliative toxin B specifically cleaves desmoglein 1.
    Amagai M; Yamaguchi T; Hanakawa Y; Nishifuji K; Sugai M; Stanley JR
    J Invest Dermatol; 2002 May; 118(5):845-50. PubMed ID: 11982763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Staphylococcal exfoliative toxins: "molecular scissors" of bacteria that attack the cutaneous defense barrier in mammals.
    Nishifuji K; Sugai M; Amagai M
    J Dermatol Sci; 2008 Jan; 49(1):21-31. PubMed ID: 17582744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of all-trans retinoic acid and Ca++ on human skin in organ culture.
    Varani J; Fligiel SE; Schuger L; Perone P; Inman D; Griffiths CE; Voorhees JJ
    Am J Pathol; 1993 Jan; 142(1):189-98. PubMed ID: 8424454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Staphylococcal scalded skin syndrome in two immunocompetent adults caused by exfoliatin B-producing Staphylococcus aureus.
    Opal SM; Johnson-Winegar AD; Cross AS
    J Clin Microbiol; 1988 Jul; 26(7):1283-6. PubMed ID: 3137245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential pathomechanisms of epidermal necrolytic blistering diseases.
    Paquet P; Piérard GE
    Int J Mol Med; 2002 Dec; 10(6):695-9. PubMed ID: 12429994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Isolation and purification of biologically active substances from Staphylococcus aureus isolated from a skin disease. II. Isolation and purification of exfoliative toxin].
    Sugai M
    Hiroshima Daigaku Shigaku Zasshi; 1987 Dec; 19(2):402-8. PubMed ID: 3504874
    [No Abstract]   [Full Text] [Related]  

  • 15. Staphylococcal scalded skin syndrome: transmission of exfoliatin-producing Staphylococcus aureus by an asymptomatic carrier.
    Hoeger PH; Elsner P
    Pediatr Infect Dis J; 1988 May; 7(5):340-2. PubMed ID: 3380584
    [No Abstract]   [Full Text] [Related]  

  • 16. Staphylococcal scalded skin syndrome I. Purification of exfoliatin and maternal transmission of neutralizing ability against exfoliatin.
    Nishioka K; Nakano T; Hirao N; Asada Y
    J Dermatol; 1977 Feb; 4(1):13-8. PubMed ID: 16688917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Staphylococcal scalded skin syndrome].
    Beylot C; Coquard F; Doutre MS
    Rev Prat; 1988 May; 38(14):885-93. PubMed ID: 3393833
    [No Abstract]   [Full Text] [Related]  

  • 18. Recent developments in staphylococcal scalded skin syndrome.
    Ladhani S
    Clin Microbiol Infect; 2001 Jun; 7(6):301-7. PubMed ID: 11442563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding the mechanism of action of the exfoliative toxins of Staphylococcus aureus.
    Ladhani S
    FEMS Immunol Med Microbiol; 2003 Nov; 39(2):181-9. PubMed ID: 14625102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Staphylococcal scalded skin syndrome: exfoliative toxin A (ETA) induces serine protease activity when combined with A431 cells.
    Ladhani S; Poston SM; Joannou CL; Evans RW
    Acta Paediatr; 1999 Jul; 88(7):776-9. PubMed ID: 10447140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.